Loading insider details...
Beta
Latest Form 4 (Jun 13, 2024): Grant/Award of 800 EFTR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 13, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 800 | n/a |
| Mar 22, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to Issuer | 30,000 | n/a |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 2,000 | n/a |
| Feb 17, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Other (see footnotes) | 5,828 | n/a |
| Jan 26, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Grant/Award | 14,010 | n/a |
| Sep 11, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 40,000 | n/a |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Oct 12, 2021 | PHOENIX BIOTECH ACQUISITION CORP. (PBAX) | Other (see footnotes) | 17,500 | n/a |
| Jan 14, 2021 | Locust Walk Acquisition Corp. (LWAC) | Other (see footnotes) | 17,500 | n/a |
| Jan 6, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |